Medtronic Long-Term Investments 2010-2025 | MDT
Medtronic long-term investments from 2010 to 2025. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Medtronic long-term investments for the quarter ending January 31, 2025 were $0M, a 0% increase year-over-year.
- Medtronic long-term investments for 2024 were $0B, a 0% decline from 2023.
- Medtronic long-term investments for 2023 were $0B, a 0% decline from 2022.
- Medtronic long-term investments for 2022 were $0B, a 0% decline from 2021.
| Medtronic Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $6,116 |
| 2010 | $4,632 |
| 2009 | $2,769 |
| Medtronic Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2025-01-31 | |
| 2024-10-31 | |
| 2024-07-31 | |
| 2024-04-30 | |
| 2024-01-31 | |
| 2023-10-31 | |
| 2023-07-31 | |
| 2023-04-30 | |
| 2023-01-31 | |
| 2022-10-31 | |
| 2022-07-31 | |
| 2022-04-30 | |
| 2022-01-31 | |
| 2021-10-31 | |
| 2021-07-31 | |
| 2021-04-30 | |
| 2021-01-31 | |
| 2020-10-31 | |
| 2020-07-31 | |
| 2020-04-30 | |
| 2020-01-31 | |
| 2019-10-31 | |
| 2019-07-31 | |
| 2019-04-30 | |
| 2019-01-31 | |
| 2018-10-31 | |
| 2018-07-31 | |
| 2018-04-30 | |
| 2018-01-31 | |
| 2017-10-31 | |
| 2017-07-31 | |
| 2017-04-30 | |
| 2017-01-31 | |
| 2016-10-31 | |
| 2016-07-31 | |
| 2016-04-30 | |
| 2016-01-31 | |
| 2015-10-31 | |
| 2015-07-31 | |
| 2015-04-30 | |
| 2015-01-31 | |
| 2014-10-31 | |
| 2014-07-31 | |
| 2014-04-30 | |
| 2014-01-31 | |
| 2013-10-31 | |
| 2013-07-31 | |
| 2013-04-30 | |
| 2013-01-31 | $9,321 |
| 2012-10-31 | $8,816 |
| 2012-07-31 | $8,259 |
| 2012-04-30 | |
| 2012-01-31 | $7,096 |
| 2011-10-31 | $7,013 |
| 2011-07-31 | $6,655 |
| 2011-04-30 | $6,116 |
| 2011-01-31 | $5,578 |
| 2010-10-31 | $5,448 |
| 2010-07-31 | $5,057 |
| 2010-04-30 | $4,632 |
| 2010-01-31 | $4,020 |
| 2009-10-31 | $3,751 |
| 2009-07-31 | $3,037 |
| 2009-04-30 | $2,769 |
| 2009-01-31 | $2,641 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $107.169B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||